Effect of Liraglutide, Metformin, and Gliclazide on Body Composition in Type 2 Diabetic Patients with Nonalcoholic Fatty Liver Disease-A Randomised Trial

被引：0
|
作者：
Feng, Wenhuan
Bi, Yan
Li, Ping
Yin, Tingting
Gao, Caixia
Shen, Shanmei
Gao, Lijun
Jiang, Can
Zhu, Dalong
机构：
来源：
DIABETES | 2018年 / 67卷
关键词：
D O I：
10.2337/db18-1344-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Effects of liraglutide, metformin and gliclazide on body composition in patients with both type 2 diabetes and non-alcoholic fatty liver disease: A randomized trial
    Feng, Wen-Huan
    Bi, Yan
    Li, Ping
    Yin, Ting-Ting
    Gao, Cai-Xia
    Shen, Shan-Mei
    Gao, Li-Jun
    Yang, Dong-Hui
    Zhu, Da-Long
    JOURNAL OF DIABETES INVESTIGATION, 2019, 10 (02) : 399 - 407
  • [2] Therapeutic effect of liraglutide on type 2 diabetic patients with nonalcoholic fatty liver disease
    Xu, Limao
    Wu, Chengfeng
    Liu, Chengmin
    Ye, Zhiyao
    Huang, Juan
    MINERVA SURGERY, 2023, 78 (04): : 448 - 450
  • [3] The effect of liraglutide on nonalcoholic fatty liver disease in type 2 diabetes mellitus
    Zhang, Xueyang
    Bai, Ran
    Jia, Yong
    Zong, Junwei
    Wang, Yongbo
    Dong, Yanan
    INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES, 2020, 40 (04) : 491 - 499
  • [4] The effect of liraglutide on nonalcoholic fatty liver disease in type 2 diabetes mellitus
    Xueyang Zhang
    Ran Bai
    Yong Jia
    Junwei Zong
    Yongbo Wang
    Yanan Dong
    International Journal of Diabetes in Developing Countries, 2020, 40 : 491 - 499
  • [5] Liraglutide, sitagliptin, and insulin glargine added to metformin: The effect on body weight and intrahepatic lipid in patients with type 2 diabetes mellitus and nonalcoholic fatty liver disease
    Science Foundation in China, 2019, (03) : 32 - 32
  • [6] Liraglutide, Sitagliptin, and Insulin Glargine Added to Metformin: The Effect on Body Weight and Intrahepatic Lipid in Patients With Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease
    Yan, Jinhua
    Yao, Bin
    Kuang, Hongyu
    Yang, Xubin
    Huang, Qin
    Hong, Tianpei
    Li, Yushu
    Dou, Jingtao
    Yang, Wenying
    Qin, Guijun
    Yuan, Huijuan
    Xiao, Xinhua
    Luo, Sihui
    Shan, Zhongyan
    Deng, Hongrong
    Tan, Ying
    Xu, Fen
    Xu, Wen
    Zeng, Longyi
    Kang, Zhuang
    Weng, Jianping
    HEPATOLOGY, 2019, 69 (06) : 2414 - 2426
  • [7] Randomized trial comparing the effects of gliclazide, liraglutide, and metformin on diabetes with non-alcoholic fatty liver disease
    Feng, Wenhuan
    Gao, Caixia
    Bi, Yan
    Wu, Min
    Li, Ping
    Shen, Shanmei
    Chen, Wei
    Yin, Tingting
    Zhu, Dalong
    JOURNAL OF DIABETES, 2017, 9 (08) : 800 - 809
  • [8] The effect of metformin on leptin in obese patients with type 2 diabetes mellitus and nonalcoholic fatty liver disease
    Nar, A.
    Gedik, O.
    ACTA DIABETOLOGICA, 2009, 46 (02) : 113 - 118
  • [9] The effect of metformin on leptin in obese patients with type 2 diabetes mellitus and nonalcoholic fatty liver disease
    A. Nar
    O. Gedik
    Acta Diabetologica, 2009, 46 : 113 - 118
  • [10] Liraglutide 0.9 mg improves liver function and fibrosis in type 2 diabetic patients with nonalcoholic fatty liver disease regardless of BMI
    Shiomi, M.
    Tanaka, Y.
    Takada, T.
    Otori, K.
    DIABETOLOGIA, 2019, 62 : S362 - S362
12345